USFDA issues Establishment Inspection Report for SMS Pharma’s Bachupally facility

22 Jan 2018 Evaluate

SMS Pharmaceuticals has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for its facility - Unit-II, located at Plot No.24 & 24B and 36 & 37, S.V. Co-operative Industrial Estate, Bachupally, Ranga Reddy District, Hyderabad. This facility was inspected by USFDA in November 2017 and there were no ‘Form 483’ observations during the inspection.

SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. They are the single largest producer of anti-ulcer products.


SMS Pharmaceuticals Share Price

208.15 -0.55 (-0.26%)
25-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.